Pharsight

Drugs that contain Sincalide

1. Kinevac patents expiration

KINEVAC Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6803046 BRACCO Sincalide formulations
Aug, 2022

(1 year, 6 months ago)

Treatment: NA

Dosage: INJECTABLE;INJECTION

More Information on Dosage

KINEVAC family patents

Family Patents

2. Sincalide patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US11318100 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

US11110063 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

US11737983 MAIA PHARMS INC Storage stable sincalide formulations
Apr, 2038

(14 years from now)

Market Authorisation Date: 22 November, 2022

Treatment: Accelerate the transit of a barium meal through the small bowel, thereby decreasing the time and extent of radiation associated with fluoroscopy and x-ray examination of the intestinal tract; Stimulat...

Dosage: POWDER;INTRAVENOUS

More Information on Dosage

SINCALIDE family patents

Family Patents